A Novel Adoptive Synthetic TCR and Antigen Receptor (STAR) T-cell Therapy for B-cell Acute Lymphoblastic Leukemia

Researchers developed a TRC complex-based chimeric antigen receptor named STAR. They reported pre-clinical and phase I clinical trial data of this T cell therapy for refractory and relapsed B cell acute lymphoblastic leukemia patients.